Stockreport

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1 [Yahoo! Finance]

Telomir Pharmaceuticals, Inc.  (TELO) 
PDF Began geriatric canine study on May 28th with initial dosing of Telomir-1 – All Animals Tolerated Dosing Well – Data will explore the potential for treatment of age-rel [Read more]